A Plus Biotechnology Co., Ltd. (TPE:6918)
Taiwan · Delayed Price · Currency is TWD 73.00
-0.10 (-0.14%)
At close: May 28, 2026
A Plus Biotechnology Market Cap
A Plus Biotechnology has a market cap or net worth of 2.47 billion as of May 29, 2026. Its market cap has decreased by -24.60% in one year.
Market Cap
2.47B
Enterprise Value
2.02B
Revenue
858.89M
Ranking
n/a
PE Ratio
14.30
Stock Price
73.00
Market Cap Chart
Since January 6, 2023, A Plus Biotechnology's market cap has increased from 1.52B to 2.47B, an increase of 62.11%. That is a compound annual growth rate of 15.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 2.47B | -16.44% |
| Dec 31, 2025 | 2.96B | 20.95% |
| Dec 31, 2024 | 2.44B | 77.04% |
| Dec 29, 2023 | 1.38B | -9.40% |
| Jan 6, 2023 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonraybio | 3.72B |
| WeLeader Biomedical | 3.05B |
| Applied BioCode | 2.54B |
| Wellell | 2.40B |
| Medimaging Integrated Solution | 2.38B |
| OK Biotech | 2.10B |
| Dynamic Medical Technologies | 2.02B |
| Taiwan Biomaterial | 1.61B |